The Hindu Business Line : Australia’s nod for Aurobindo drug

Aurobindo Pharma Australia Pty Ltd, a wholly-owned subsidiary of Aurobindo Pharma Ltd, has received approval from Therapeutic Goods Administration (TGA), Government of Australia, for the registration of Amlodipine Besylate tablets. The tablets fall under the central nervous system segment and are indicated for the first line treatment of hypertension. They can be used as the sole agent to control blood pressure in the majority of patients, the Hyderabad-based company infor med BSE. —

Our Bureau

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Australia’s nod for Aurobindo drug

Ansal Properties QIPs to raise Rs 1,500 cr

RIL-RNRL dispute: Await more twists in the tale

RIL-RNRL case: Ministry awaits Court order

Court directs Reliance to sell gas to RNRL at $2.34

Balmer Lawrie dividend

Dr Reddy’s Laboratories to hire 1,300 this year

Suzlon says it is considering options for its stake in Hansen Transmissions

GAIL to invest Rs 5,558 cr in 2009-10

British company opens facility

Teams up with GSK for drug development

Tata Motors, Bank of India tie up

TVS to ride on new bikes towards double-digit growth

Swine flu cases in India spike to 30

SAIL gets new Director of Projects